About Normunity
Normunity develops novel anti-cancer therapies, including therapeutic antibodies, bispecific antibodies, and payload-carrying biologics. These medicines target mechanisms at the interface of the immune system and tumors to impact tumor growth and circumvent immune surveillance. Normunity's customers are cancer patients, and it makes money by developing and advancing a pipeline of biologic medicines.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $75,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $65,000,000 · Series-A
startupintros.com
- Milestone
X account created (@normunity)
34 followers
- Milestone
Company founded
New Haven, United States
- Milestone
Website domain registered
normunity.com
Investors & Backers
Funding History
Founders & Leadership
Ellen Forest
Interim Head of Human Resources
Kristin Robbins
VP, Program & Portfolio Management
Melinda Merchant
Chief Medical Officer
Olga Granaturova
Chief Operating Officer and Chief Business Officer
Rachel W. Humphrey
Founder
William LaRochelle
Chief Scientific Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com